Arcosa, Inc. (ACA) Stock Forecast
ACA analyst forecast
as of October 18, 2026- Analyst consensus
- Hold 3.33 / 5 from 3 analysts
- Price target
- $146.67 average of analyst targets
- Upside to target
- −0.3% from the latest close
- Next earnings
- October 29, 2026 EPS estimate $1.56
- 52-week range
- $92.25 – $147.27
ACA analyst ratings
3 analystsNumber of analysts at each rating.
ACA price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
ACA earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $1.58 | $1.53 | $1.59 | $1.56 | +1.0% | 4 |
| Current fiscal year (2026) | $4.29 | $4.16 | $4.46 | $4.47 | −4.0% | 3 |
| Next fiscal year (2027) | $5.12 | $4.75 | $5.75 | $4.29 | +19.3% | 4 |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
ACA revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Current quarter (Sep '26) | $720.0M | $717.1M | $724.5M | −9.8% | 3 |
| Current fiscal year (2026) | $2.59B | $2.58B | $2.60B | −10.2% | 3 |
| Next fiscal year (2027) | $2.84B | $2.75B | $2.96B | +9.7% | 3 |
ACA EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
ACA revenue: reported and forecast
ACA EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $1.56 | $1.56 | $1.56 | $1.57 | $1.58 | +1.0% | 2 up · 0 down |
| Current fiscal year (2026) | $4.38 | $4.38 | $4.38 | $4.29 | $4.29 | −2.1% | 0 up · 2 down |
| Next fiscal year (2027) | $5.08 | $5.08 | $5.08 | $5.12 | $5.12 | +0.7% | 2 up · 0 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
ACA earnings surprises
Reported EPS vs the consensus estimate for the last 12 quarters; ACA beat in 10 of 12.
What analysts expect from ACA
3 analysts cover Arcosa; their consensus rating is hold (3.33 on a 1–5 scale, where 5 is a strong buy). The average price target is $146.67, 0.3% below the latest close of $147.06. Analysts expect earnings of $4.29 per share for 2026, −4.0% from a year earlier. For 2027 the average estimate is $5.12 per share on revenue of $2.8 billion. Arcosa beat the EPS estimate in 10 of the last 12 quarters.
Related: ACA income statement, ACA key metrics, ACA chart. See the ACA stock overview for the latest quote and news.
ACA forecast FAQ
What is Arcosa's price target?
The average analyst price target for Arcosa is $146.67, 0.3% below the latest close of $147.06.
Is Arcosa a buy, hold or sell?
Of 3 analysts covering Arcosa, 0 rate it a strong buy, 1 a buy, 2 a hold, 0 a sell and 0 a strong sell, a consensus of hold. Ratings are opinions, not a recommendation from Quotelinks.
What is Arcosa's EPS forecast?
Analysts forecast $4.29 per share for 2026 (range $4.16 to $4.46); for 2027 the estimate is $5.12.
What is Arcosa's revenue forecast?
The average revenue estimate for 2026 is $2.6 billion, growth of −10.2%; for 2027 it is $2.8 billion.
When does Arcosa report earnings?
Arcosa is expected to report results for the quarter ending September 30, 2026 on October 29, 2026 after the market closes; the EPS estimate is $1.56.
Does Arcosa usually beat earnings estimates?
Arcosa reported EPS at or above the analyst estimate in 10 of the last 12 quarters.